The measuring device called C3 will in the future be able to discover if the cancer patient has an irregular pulse, temperature or respiratory rate. All this without the patient being disturbed.
A central cornerstone of InnoCan is establishing a Danish-German test center. Its’ purpose is to help medtech companies develop and mature their innovative solutions for cancer patients, and this significantly faster than is the case today.
Dansk
Deutsch
English
